{"id":"https://openalex.org/W2140191908","doi":"https://doi.org/10.1093/jjco/hyi149","title":"Phase II Trial of Amsacrine Plus Intermediate-dose Ara-C (IDAC) with or without Etoposide as Salvage Therapy for Refractory or Relapsed Acute Leukemia","display_name":"Phase II Trial of Amsacrine Plus Intermediate-dose Ara-C (IDAC) with or without Etoposide as Salvage Therapy for Refractory or Relapsed Acute Leukemia","publication_year":2005,"publication_date":"2005-09-19","ids":{"openalex":"https://openalex.org/W2140191908","doi":"https://doi.org/10.1093/jjco/hyi149","mag":"2140191908","pmid":"https://pubmed.ncbi.nlm.nih.gov/16172175"},"language":"en","primary_location":{"id":"doi:10.1093/jjco/hyi149","doi":"https://doi.org/10.1093/jjco/hyi149","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jjco/hyi149","pdf_url":null,"source":{"id":"https://openalex.org/S149902429","display_name":"Japanese Journal of Clinical Oncology","issn_l":"0368-2811","issn":["0368-2811","1465-3621"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2140191908"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111955514","display_name":"Woo Jin Sung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801673063","display_name":"Kyungpook National University Hospital","ror":"https://ror.org/04qn0xg47","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2801673063","https://openalex.org/I31419693"]}],"countries":["KR"],"is_corresponding":true,"raw_author_name":"Woo Jin Sung","raw_affiliation_strings":["Department of Hematology/Oncology, Kyungpook National University Hospital, Jung-gu, Daegu 700-721, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology/Oncology, Kyungpook National University Hospital, Jung-gu, Daegu 700-721, Korea","institution_ids":["https://openalex.org/I2801673063"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113434045","display_name":"Dong Hwan Kim","orcid":"https://orcid.org/0000-0001-8982-7917","observed_orcids":["https://orcid.org/0000-0001-8982-7917"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dong Hwan Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103193360","display_name":"Sang Kyun Sohn","orcid":"https://orcid.org/0000-0003-1932-0429","observed_orcids":["https://orcid.org/0000-0003-1932-0429","https://orcid.org/0000-0002-1874-3959"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sang Kyun Sohn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062251564","display_name":"Jong Gwang Kim","orcid":"https://orcid.org/0000-0002-7615-5864","observed_orcids":["https://orcid.org/0000-0002-7615-5864"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jong Gwang Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086071252","display_name":"Jin Ho Baek","orcid":"https://orcid.org/0000-0003-2523-9950","observed_orcids":["https://orcid.org/0000-0003-2523-9950"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jin Ho Baek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103562244","display_name":"Seok Bong Jeon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seok Bong Jeon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036888293","display_name":"Joon Ho Moon","orcid":"https://orcid.org/0000-0003-3756-796X","observed_orcids":["https://orcid.org/0000-0003-3756-796X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joon Ho Moon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109830770","display_name":"Byung Min Ahn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Byung Min Ahn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5009207724","display_name":"Kyu Bo Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kyu Bo Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111955514"],"corresponding_institution_ids":["https://openalex.org/I2801673063"],"apc_list":{"value":3604,"currency":"USD","value_usd":3604},"apc_paid":null,"fwci":0.7665,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.72420153,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"35","issue":"10","first_page":"612","last_page":"616"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amsacrine","display_name":"amsacrine","score":0.9890000224113464},{"id":"https://openalex.org/keywords/intermediate-dose-cytarabine","display_name":"intermediate-dose cytarabine","score":0.9660000205039978},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/salvage-therapy","display_name":"salvage therapy","score":0.949999988079071},{"id":"https://openalex.org/keywords/refractory-acute-leukemia","display_name":"refractory acute leukemia","score":0.875},{"id":"https://openalex.org/keywords/relapsed-acute-leukemia","display_name":"relapsed acute leukemia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":1.0},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":1.0},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.9440000057220459},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.796999990940094},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.6660000085830688},{"id":"https://openalex.org/keywords/central-nervous-system-toxicity","display_name":"central nervous system toxicity","score":0.8090000152587891}],"concepts":[{"id":"https://openalex.org/C2780500152","wikidata":"https://www.wikidata.org/wiki/Q2784004","display_name":"Amsacrine","level":4,"score":0.9777234792709351},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8695945739746094},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.7969920039176941},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.7506538033485413},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6207038164138794},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5557102560997009},{"id":"https://openalex.org/C2776863199","wikidata":"https://www.wikidata.org/wiki/Q976388","display_name":"Acute leukemia","level":3,"score":0.5493447780609131},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5175780057907104},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4852602183818817},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4547313153743744},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.444292813539505},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.43269115686416626},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40856802463531494},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3971823751926422},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.34613046050071716},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000677","descriptor_name":"Amsacrine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014840","descriptor_name":"Vomiting, Anticipatory","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016879","descriptor_name":"Salvage Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1093/jjco/hyi149","doi":"https://doi.org/10.1093/jjco/hyi149","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jjco/hyi149","pdf_url":null,"source":{"id":"https://openalex.org/S149902429","display_name":"Japanese Journal of Clinical Oncology","issn_l":"0368-2811","issn":["0368-2811","1465-3621"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:16172175","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16172175","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese journal of clinical oncology","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.505.9032","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.505.9032","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jjco.oxfordjournals.org/content/early/2005/09/19/jjco.hyi149.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.505.9440","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.505.9440","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jjco.oxfordjournals.org/content/35/10/612.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W24153442","https://openalex.org/W70062372","https://openalex.org/W110832747","https://openalex.org/W1143126211","https://openalex.org/W1881046587","https://openalex.org/W1934064433","https://openalex.org/W1968626722","https://openalex.org/W1977171869","https://openalex.org/W2023291141","https://openalex.org/W2029692863","https://openalex.org/W2033902902","https://openalex.org/W2040802744","https://openalex.org/W2062064479","https://openalex.org/W2077099625","https://openalex.org/W2079031490","https://openalex.org/W2120220515","https://openalex.org/W2138906968","https://openalex.org/W2143532069","https://openalex.org/W2156689952","https://openalex.org/W2183853859","https://openalex.org/W2211072972","https://openalex.org/W2306571443","https://openalex.org/W2339359539","https://openalex.org/W2410504990"],"related_works":["https://openalex.org/W54826626","https://openalex.org/W2396417132","https://openalex.org/W2076477731","https://openalex.org/W3021648246","https://openalex.org/W2106491226","https://openalex.org/W279276949","https://openalex.org/W2286132081","https://openalex.org/W2306571443","https://openalex.org/W2263355311"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1,83],"current":[2,51],"trial":[3],"attempted":[4],"to":[5,159],"evaluate":[6],"the":[7,50,97],"efficacy":[8],"and":[9,68,96,137,162],"toxicity":[10,141],"of":[11,16,38,64,100,150],"a":[12,61,168],"salvage":[13,62,147],"therapy":[14,63,148,166],"consisting":[15,149],"amsacrine":[17,65,79,151],"plus":[18,66,80,152],"intermediate-dose":[19],"Ara-C":[20],"(IDAC)":[21],"with":[22,41,55,73,154,175],"or":[23,32,43,155,177],"without":[24,156],"etoposide":[25,157],"for":[26,91,94,173],"acute":[27,45,56,74,179],"leukemia":[28,46,58,76],"patients":[29,40,54,72,121,174],"in":[30,49,119],"refractory":[31,42,176],"relapsed":[33,44,178],"states.":[34],"METHODS:":[35],"A":[36,146],"total":[37],"51":[39],"were":[47,117],"included":[48,129],"trial.":[52],"Twenty-nine":[53],"myeloid":[57],"(AML)":[59],"received":[60,78],"IDAC":[67,153],"etoposide,":[69],"while":[70,123],"22":[71],"lymphoblastic":[75],"(ALL)":[77],"IDAC.":[81],"RESULTS:":[82],"overall":[84,101],"complete":[85],"remission":[86],"rate":[87],"was":[88,103],"55%":[89],"(45%":[90],"AML,":[92],"68%":[93],"ALL)":[95],"median":[98],"duration":[99],"survival":[102],"144":[104],"days":[105],"(95%":[106],"confidence":[107],"interval":[108],"=":[109,135,143],"101-186":[110],"days).":[111],"Grade":[112],"3,":[113],"4":[114],"infectious":[115,127],"toxicities":[116],"observed":[118],"43":[120],"(87%),":[122],"treatment-related":[124],"toxicity,":[125],"excluding":[126],"causes,":[128],"heart":[130],"failure":[131],"from":[132],"myocarditis":[133],"(n":[134,142],"1)":[136],"central":[138],"nervous":[139],"system":[140],"1).":[144],"CONCLUSION:":[145],"appears":[158],"be":[160],"safe":[161],"an":[163],"effective":[164],"bridge":[165],"into":[167],"stem":[169],"cell":[170],"transplantation":[171],"programme":[172],"leukemia.":[180]},"counts_by_year":[{"year":2023,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
